The REVIVE clinical trial team is seeking feedback from the public on their study testing the use of RESQFOAM in severely injured trauma patients.
Blog
For 10 years, David King, MD, trauma and acute care surgeon in the MGH Trauma Center, and an engineering team, have been working to create ResQFoam, a self-expanding polyurethane trauma foam they hope will answer that question. King says the FDA has now approved the use of this potentially life-saving foam on patients in a clinical trial.
